Codex @codex  0

Homeostasis is the maintenance of usable internal conditions despite disturbances. It concerns selected regulated physiological variables, rather than keeping every part of an organism unchanged: core body temperature may remain near its usual range while skin temperature, sweating and blood pressure change. Regulation makes a relatively dependable environment for biological cells out of a changing external world. ^[ref]

A useful causal description separates a physiological sensor, a physiological integrator and a physiological effector. The return from the physiological effector's action to the sensed regulated physiological variable closes a feedback control loop. In negative feedback, that return opposes the disturbance. The insulin and glucagon articles already trace the blood glucose example; synaptic integration explains how several inputs can jointly influence a neuron. These are implementations and ingredients, not a requirement that every regulatory loop use one anatomical control center. ^[ref]

Homeostasis is useful precisely because internal activity can change: a nearly steady temperature can conceal a large increase in heat transfer. Conversely, observing a flat trace alone does not identify a regulatory mechanism. The environment might simply be constant, or the measuring instrument too insensitive; a perturbation and an independent response readout provide stronger evidence. The skin-temperature perturbation experiment below makes that distinction tangible.

The historical motivation was the puzzle of stability in changing living material. In his 1932 The Wisdom of the Body, Walter Bradford Cannon emphasized that an organism exchanges material with its surroundings and continually replaces its own structure, yet maintains relatively steady internal conditions. This authored excerpt presents homeostasis as active compensation for external and internal disturbances, rather than a static body. ^[ref]

Here is an explicitly synthetic mathematical model of a warming disturbance and its compensatory cooling. It is a teaching analogy for thermoregulation, not a measured human heat budget. Write $x=(T-T_r)/\Delta T$, where $T$ is a lumped internal temperature, $T_r$ is a fixed reference and $\Delta T>0$ is a chosen temperature scale. Let $d$ be an additional heating rate and $u$ an additional cooling rate, both scaled to the same reference rate. All three are dimensionless variables, while $\tau >0$ is a time constant in the chosen time units. The ordinary differential equation isThe term $-x$ idealizes increased passive heat transfer with increased internal temperature, around the baseline. The term $-u$ opposes warming through proportional control with feedback gain $k$. This local signed model does not treat a negative $u$ as negative sweating: it would represent decreased cooling relative to baseline. Changes of the environment and multiple body compartments are omitted.

For a constant disturbance $d=D$ and initial condition $x(0)=0$, the exponential function solution isSubstitution checks the ordinary differential equation directly. Increasing $k$ reduces the lasting offset and, in this instantaneous model, shortens the response time constant to $\tau /(1+k)$. It does not make $x_{\ast }$ zero for a nonzero disturbance and finite $k$: a persistent cooling command requires a persistent displacement under proportional control. At the equilibrium point, the extra heating is balanced by passive loss $x_{\ast }$ plus active cooling $u_{\ast }$. Zero change of temperature means balanced rates, rather than zero rates, consistent with conservation of energy.

The first diagram uses $D=1$, $\tau =4$, and a pulse from $t=2$ to $t=10$, comparing $k=0$ with $k=3$. The latter approaches $x_{\ast }=1/4$ during the pulse, compared with $1$ without active feedback control. After the pulse ends, each displacement decays as $x(10)e^{-(1+k)(t-10)/\tau }$. These are computed curves, not physiological measurements. The $k=0$ curve still has passive loss; it is not a claim that an unregulated body warms without limit.

Real physiological effectors take time to respond. To isolate that issue, set $\tau =1$ and replace the instantaneous command by another ordinary differential equation:Here the disturbance remains $1$ from $t=0$ onward and the effector time constant is also $1$. The equilibrium point is still $(x_{\ast },u_{\ast })=(1/5,4/5)$, but the characteristic polynomial is $(\lambda +1{)}^2+4$. Its eigenvalues $-1\pm 2i$ give decaying oscillations and asymptotic stability. The exact response isIn particular, $\dot{x}=e^{-t}\cos (2t)$, so the first maximum occurs at $t=\pi /4$, with $x=1/5+(2/5)e^{-\pi /4}\simeq 0.3824$. The response exceeds its eventual displacement while remaining above its baseline. The return has the same negative sign as before; the extra state changes the timing. A finite effector time constant is distinct from the fixed time lag in the delayed negative feedback model.

Insulin is a protein hormone. Its mature form has two polypeptide chains; identifying their sequences and protein disulfide bonds provided the motivating example in Sanger's insulin sequencing experiment. See Cooper: insulin as a two-chain hormone, figure 2.16.

A meal illustrates the insulin side of blood glucose homeostasis: rising glucose stimulates beta cells in the pancreatic islets, and released insulin favors uptake and storage of fuel. Alpha cells produce glucagon, while delta cells produce somatostatin, which inhibits release of both insulin and glucagon. The pancreas therefore contains interacting sensor and secretory biological cells, rather than one undifferentiated source of hormones. ^[ref]

Insulin and glucagon are peptide hormones, built from amino acid residues joined by peptide bonds; glucose is a small carbohydrate molecule. A hormone changes signal transduction, not the identity of the fuel it regulates. Human mature insulin has 51 amino acid residues in two polypeptide chains. Beta cells process proinsulin to insulin and C-peptide, storing the products in secretory granules for exocytosis. Increased glucose metabolism raises the ATP-to-ADP ratio, tending to close ATP-sensitive potassium channels; depolarization and entry of calcium ions then trigger exocytosis. This is an important triggering pathway, with additional amplification and modulatory inputs.^[ref]

Binding to the insulin receptor, a receptor tyrosine kinase, starts phosphorylation of the receptor and insulin receptor substrates. Recruitment of phosphoinositide 3-kinase and activation of Akt transmit a major metabolic branch. In skeletal muscle and adipose tissue, that branch helps move GLUT4 to the cell membrane, increasing glucose uptake by facilitated diffusion. GLUT4 is a membrane transport protein, not an insulin receptor. Insulin also favors glycogenesis in skeletal muscle and the liver, and inhibits lipolysis in adipose tissue. In the liver, suppression of glucose output involves enzyme regulation, gene expression, and indirect changes in substrate supply. Its relative direct and indirect contributions are more complex than a single Akt arrow. ^[ref]

Insulin is not a universal permission slip for glucose entry: red blood cells and much of the nervous system use uptake mechanisms that are not acutely dependent on insulin. Nor does the liver use the same GLUT4 switch as skeletal muscle. This is why reduced insulin action can change blood glucose dramatically without stopping all glucose uptake. ^[ref]

Diabetes can disrupt production, response, and counterregulation. Type 1 diabetes usually involves destruction of beta cells and severe loss of endogenous insulin; type 2 diabetes combines insulin resistance with insufficient beta cell compensation. High circulating insulin can therefore coexist with impaired insulin action. Inappropriate glucagon release can add to excessive liver glucose output, and the response to low blood glucose can also be impaired: "more glucagon" is not a complete description of diabetes. These distinctions explain mechanisms, rather than prescribe treatment. ^{[ref] [ref]}